FARMACOTERAPIA Y SEGURIDAD DE LOS MEDICAMENTOS
Universitat Autònoma de Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Universitat Autònoma de Barcelona (4)
2016
-
CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: A case-control study
Pharmacogenetics and Genomics, Vol. 26, Núm. 2, pp. 66-73
2011
-
Selective serotonin reuptake inhibitors and gastrointestinal bleeding: A case-control study
PLoS ONE, Vol. 6, Núm. 5
-
Synergism between prior Anisakis simplex infections and intake of NSAIDs, on the risk of upper digestive bleeding: A case-control study
PLoS Neglected Tropical Diseases, Vol. 5, Núm. 6
2009
-
Prevalence of CYP2C9 polymorphisms in the south of Europe
Pharmacogenomics Journal, Vol. 9, Núm. 5, pp. 306-310